Multicenter Phase 2 Study about the Safety of No Antimicrobial Prophylaxis Use in Low-Risk Patients Undergoing Laparoscopic Distal Gastrectomy for Gastric Carcinoma (KSWEET-01 Study)
Table 4
Multivariate analysis of risk factors for SSI.
Univariate
Multivariate
OR (95% CI)
Adjusted OR (95% CI)
Age (years)
1.04 (0.97–1.13)
0.281
Male
1.29 (0.39–4.29)
0.676
BMI
1.16 (0.99–1.35)
0.073
1.19 (0.99–1.45)
0.058
Comorbidity
0.66 (0.19–2.30)
0.516
Preoperative albumin
0.14 (0.03–0.79)
0.025
0.45 (0.03–7.39)
0.574
Extracorporeal anastomosis
16.55 (1.39–197.70)
0.027
78.70 (3.18–1948.98)
0.008
D2 LND
7.62 (1.95–29.82)
0.004
7.45 (1.15–48.06)
0.035
RYGJ
0.17 (0.03–0.81)
0.026
0.17 (0.02–1.48)
0.108
Omentectomy
1.01 (0.11–8.96)
0.992
Operating time
0.99 (0.98–1.00)
0.166
Operative blood loss
1.01 (0.99–1.02)
0.151
SSI preventive measures
0.24 (0.06–0.95)
0.043
0.63 (0.11–3.79)
0.613
BMI: body mass index; LND: lymph node dissection; RYGJ: Roux-en-Y gastrojejunostomy; SSI: surgical site infection; OR: odds ratio; CI: confidence interval.
